Chemed (CHE) Receivables - Other (2010 - 2025)

Chemed has reported Receivables - Other for 15 years, with the latest figure at $8.6 million in Q4 2025.

• Receivables - Other for Q4 2025 came in at $8.6 million, down 1.58% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.6 million (down 1.58% YoY), and the FY2025 annual result was $8.6 million, down 1.58% from the prior year.
• Receivables - Other grew to $8.6 million in Q4 2025, from $8.1 million in the prior quarter.
• Over five years, Receivables - Other peaked at $8.8 million in Q4 2024 and troughed at $1.5 million in Q2 2025.
• A 5-year average of $3.1 million and a median of $1.8 million in 2024 frame the typical range for Receivables - Other.
• The widest annual swing landed in 2024, when Receivables - Other surged 428.5%; it then declined 24.48% in 2025.
• A 5-year view of Receivables - Other shows it stood at $1.9 million in 2021, then dropped by 3.59% to $1.8 million in 2022, then dropped by 8.93% to $1.7 million in 2023, then surged by 428.5% to $8.8 million in 2024, then fell by 1.58% to $8.6 million in 2025.
• Per Business Quant data, the three most recent Receivables - Other figures were $8.6 million in Q4 2025, $8.1 million in Q3 2025, and $1.5 million in Q2 2025.